Search

everythinglearnresearchcommunity

for

Search:↓

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

HGF-modified hair follicle stem cells help brain recovery after injury in rats.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Intralesional triamcinolone effectively reduces pain and inflammation in hidradenitis suppurativa flares.

Cimetidine does not significantly reduce hair growth in hirsutism.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Irradiating the whole central nervous system can lead to over 50% of patients with cerebellar medulloblastoma surviving three years.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Hormonal treatments can effectively improve hidradenitis suppurativa symptoms.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Skin stem cells were turned into heart cells using a chemical, suggesting a new way to treat heart attacks.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

A man with Isaac's syndrome affecting only one side of his body improved after immune system-targeted treatment.

Bimekizumab effectively treated a man's chronic beard hair loss.

The combined treatment of a specific hair cocktail and microneedling device effectively restores hair in different baldness patterns.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.